Regan JA - Search Results

1

Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.

Regan JA, Cao Y, Dispenza MC, Ma S, Gordon LI, Petrich AM, Bochner BS. Regan JA, et al. J Allergy Clin Immunol. 2017 Sep;140(3):875-879.e1. doi: 10.1016/j.jaci.2017.03.013. Epub 2017 Apr 4. J Allergy Clin Immunol. 2017. PMID: 28389390 Free PMC article. No abstract available.

2

Potential applications of Bruton's tyrosine kinase inhibitors for the prevention of allergic reactions.

Dispenza MC, Regan JA, Bochner BS. Dispenza MC, et al. Among authors: regan ja. Expert Rev Clin Immunol. 2017 Oct;13(10):921-923. doi: 10.1080/1744666X.2017.1370374. Epub 2017 Aug 31. Expert Rev Clin Immunol. 2017. PMID: 28829205 Free PMC article. No abstract available.

3

Viral transformation of epithelial cells.

Regan JA, Laimins LA. Regan JA, et al. Methods Mol Biol. 2013;945:449-65. doi: 10.1007/978-1-62703-125-7_26. Methods Mol Biol. 2013. PMID: 23097122

4

Bap31 is a novel target of the human papillomavirus E5 protein.

Regan JA, Laimins LA. Regan JA, et al. J Virol. 2008 Oct;82(20):10042-51. doi: 10.1128/JVI.01240-08. Epub 2008 Aug 6. J Virol. 2008. PMID: 18684816 Free PMC article.

5

Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation.

Kotnik Halavaty K, Regan J, Mehta K, Laimins L. Kotnik Halavaty K, et al. Virology. 2014 Mar;452-453:223-30. doi: 10.1016/j.virol.2014.01.013. Epub 2014 Feb 14. Virology. 2014. PMID: 24606699 Free PMC article.

6

Identification of single amino acid substitutions in the staphylococcal nuclease protein that enhance and diminish T cell clone recognition of naturally processed peptides.

Finnegan A, Regan J, Seamon KB, Lindholm C. Finnegan A, et al. Int Immunol. 1992 Dec;4(12):1399-406. doi: 10.1093/intimm/4.12.1399. Int Immunol. 1992. PMID: 1286063

7

Should We Systematically Screen for the Amyloidogenic V142I Variant?

Regan JA, Khouri MG, Olabisi OA, Alexander KM, Khan SS, Shah SH, Selvaraj S. Regan JA, et al. J Card Fail. 2024 Sep 19:S1071-9164(24)00383-X. doi: 10.1016/j.cardfail.2024.08.055. Online ahead of print. J Card Fail. 2024. PMID: 39306232 No abstract available.

8

Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection.

Regan JA, Fontana M, Selvaraj S. Regan JA, et al. JAMA Cardiol. 2024 Nov 1;9(11):957-959. doi: 10.1001/jamacardio.2024.2654. JAMA Cardiol. 2024. PMID: 39196584 No abstract available.

9

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.

Regan JA, Mentz RJ, Nguyen M, Green JB, Truby LK, Ilkayeva O, Newgard CB, Buse JB, Sourij H, Sjöström CD, Sattar N, McGarrah RW, Zheng Y, McGuire DK, Standl E, Armstrong P, Peterson ED, Hernandez AF, Holman RR, Shah SH. Regan JA, et al. JCI Insight. 2023 Sep 8;8(17):e168563. doi: 10.1172/jci.insight.168563. JCI Insight. 2023. PMID: 37552540 Free PMC article.

10

The association of accelerated epigenetic age with all-cause mortality in cardiac catheterization patients as mediated by vascular and cardiometabolic outcomes.

Jiang R, Hauser ER, Kwee LC, Shah SH, Regan JA, Huebner JL, Kraus VB, Kraus WE, Ward-Caviness CK. Jiang R, et al. Among authors: regan ja. Clin Epigenetics. 2022 Dec 3;14(1):165. doi: 10.1186/s13148-022-01380-x. Clin Epigenetics. 2022. PMID: 36461124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters